We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Prosperity Bancshares
PB
$8.77B
| $1.56M | 0.03% |
28,490
+310
| +1% | +$16.4K |
|
477
Clean Energy Fuels
CLNE
$447M
| $1.56M | 0.03% |
348,267
-2,100
| -0.6% | -$8.02K |
|
478
Stride
LRN
$3.69B
| $1.56M | 0.03% |
108,480
+5,503
| +5% | +$70.2K |
|
|
LHCG
479
DELISTED
LHC Group LLC
LHCG
| $1.54M | 0.03% |
41,774
+22,439
| +116% | +$899K |
|
480
Astronics
ATRO
$3.45B
| $1.53M | 0.03% |
53,898
+30,852
| +134% | +$789K |
|
481
AeroVironment
AVAV
$7.57B
| $1.53M | 0.03% |
62,602
+1,050
| +2% | +$28.2K |
|
|
GWB
482
DELISTED
Great Western Bancorp, Inc.
GWB
| $1.52M | 0.03% |
45,544
-100,666
| -69% | -$3.32M |
|
483
NewMarket
NEU
$7.17B
| $1.51M | 0.03% |
3,521
+1,874
| +114% | +$798K |
|
|
MASI
484
DELISTED
Masimo
MASI
| $1.5M | 0.03% |
25,230
+8,500
| +51% | +$480K |
|
|
ALOG
485
DELISTED
Analogic Corp
ALOG
| $1.5M | 0.03% |
16,900
+2,470
| +17% | +$214K |
|
486
Brown-Forman Class B
BF.B
$12B
| $1.48M | 0.03% |
+48,828
| New | +$1.52M |
|
|
ALX
487
Alexander's
ALX
$1.4B
| $1.48M | 0.03% |
3,525
+756
| +27% | +$325K |
|
488
Crown Holdings
CCK
$12.8B
| $1.47M | 0.03% |
25,793
-770
| -3% | -$41.3K |
|
489
Silicon Laboratories
SLAB
$7.15B
| $1.47M | 0.03% |
+24,910
| New | +$1.35M |
|
|
INVN
490
DELISTED
Invensense Inc
INVN
| $1.45M | 0.03% |
+195,700
| New | +$1.39M |
|
491
Toro Company
TTC
$8.93B
| $1.45M | 0.03% |
+30,850
| New | +$1.44M |
|
|
TBI
492
Trueblue
TBI
$234M
| $1.44M | 0.03% |
63,497
+50,197
| +377% | +$1.1M |
|
493
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
| $1.43M | 0.03% |
5,080
| – | – |
|
|
DFT
494
DELISTED
DuPont Fabros Technology Inc.
DFT
| $1.43M | 0.03% |
34,708
+3,400
| +11% | +$153K |
|
|
ABMD
495
DELISTED
Abiomed Inc
ABMD
| $1.42M | 0.03% |
+11,020
| New | +$1.32M |
|
|
BCOV
496
DELISTED
Brightcove, Inc.
BCOV
| $1.4M | 0.03% |
107,388
+21,300
| +25% | +$243K |
|
497
Kelly Services Class A
KELYA
$526M
| $1.4M | 0.03% |
72,863
+10,603
| +17% | +$207K |
|
498
The Greenbrier Companies
GBX
$1.61B
| $1.4M | 0.03% |
39,600
-50,728
| -56% | -$1.66M |
|
|
OSG
499
Octave Specialty Group
OSG
$252M
| $1.4M | 0.02% |
75,854
-6,500
| -8% | -$117K |
|
500
Commercial Vehicle Group
CVGI
$157M
| $1.39M | 0.02% |
240,174
+130,782
| +120% | +$643K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.